Valstar - For therapy of BCG-refractory urinary bladder carcinoma

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 1998年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1048 / 1048
页数：1
相关论文
共 50 条
  • [21] EARLY PDD CYSTOSCOPY AFTER BCG INDUCTION INCREASES DETECTION OF BCG-REFRACTORY TUMORS
    Morelli, Michele
    Baboudjian, Michael
    Tadrist, Abel
    Gondran-tellier, Bastien
    Karsenty, Gilles
    Lechevallier, Eric
    Montanari, Emanuele
    Boissier, Romain
    [J]. ANTICANCER RESEARCH, 2021, 41 (10) : 5259 - 5259
  • [22] A phase I trial for the use of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) in the treatment of BCG-refractory nonmuscle invasive urothelial carcinoma of the bladder.
    DeCastro, Guarionex Joel
    Sui, Wilson
    Pak, Jamie S.
    Abate-Shen, Corinne T.
    Lee, Shing Mirn
    Anderson, Christopher B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [23] THERAPY OF CARCINOMA OF THE URINARY BLADDER
    LOCKWOOD, IH
    CHAPMAN, SB
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1956, 75 (03): : 519 - 524
  • [24] Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial
    Perdona, Sisto
    Di Lorenzo, Giuseppe
    Cantiello, Francesco
    Damiano, Rocco
    De Sio, Marco
    Masala, Daniele
    Bruni, Gianni
    Gallo, Luigi
    Federico, Piera
    Quattrone, Carmelo
    Pizzuti, Mariano
    Autorino, Riccardo
    [J]. ANTI-CANCER DRUGS, 2010, 21 (01) : 101 - 106
  • [25] A PHASE I TRIAL FOR THE USE OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) IN THE TREATMENT OF BCG-REFRACTORY NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    DeCastro, Guarionex
    Sui, Wilson
    Pak, Jamie
    Abate-Shen, Cory
    Lee, Shing
    Anderson, Christopher
    Holder, Dara
    McKiernan, James
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E175 - E176
  • [26] Phase I clinical trial of external hyperthermia and intravesical mitomycin C to treat BCG-refractory bladder cancer.
    Abern, Michael
    Vujaskovic, Zeljko
    Dewhirst, Mark W.
    Lan, Lan
    Craciunescu, Oana I.
    Stauffer, Paul
    Inman, Brant Allen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Treatment in patients with muscle noninvasive carcinoma of the urinary bladder after unsuccessful intravesicular BCG therapy
    Figurin, K. M.
    [J]. ONKOUROLOGIYA, 2010, 6 (03): : 51 - 56
  • [28] PATHOLOGIC UPSTAGING AT THE TIME OF RADICAL CYSTECTOMY IS ASSOCIATED WITH WORSE RECURRENCE FREE SURVIVAL IN PATIENTS WITH BCG-REFRACTORY BLADDER CANCER
    Guzzo, Thomas J.
    Magheli, Ahmed
    Bivalacqua, Trinity J.
    Nielsen, Matthew E.
    Attenello, Frank
    Ball, Mark W.
    Schoenberg, Mark P.
    Gonzalgo, Mark L.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 641 - 641
  • [29] Efficacy of hyperthermic-intra-vesical chemotherapy in patients with BCG-refractory nonmuscle-invasive bladder cancer.
    Pignot, Geraldine
    Lorusso, Vito
    Doisy, Laure
    Guerin, Mathilde
    Vicier, Cecile
    Dermeche, Slimane
    Branger, Nicolas
    Maubon, Thomas
    Rybikowski, Stanislas
    Walz, Jochen
    Gravis, Gwenaelle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] Photodynamic laser therapy in refractory transitional cell carcinoma of urinary bladder - Early results
    Lipinski, M
    Jeromin, LM
    [J]. PROCEEDINGS OF THE 15TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY FOR LASER SURGERY AND MEDICINE (ISLSM), 2003, : 43 - 47
12345